Anti-EGFR	anti-epidermal growth factor receptor monoclonal antibody
BRAF	B rapidly accelerated fibrosarcoma gene
CA19-9	carbohydrate antigen 19-9
CEA	carcinoembryonic antigen
CR	complete response
CT	chemotherapy
EGFR	epidermal growth factor receptor
FOLFIRI	chemotherapy regime containing folinic acid (FOL), fluorouracil (F), and irinotecan (IRI)
FOLFOX	Chemotherapy regime containing folinic acid (FOL), fluorouracil (F), and oxaliplatin (OX)
FU	follow-up
KRAS	Kirsten rat sarcoma virus gene
LK	lymph node
mCRC	metastatic colorectal carcinoma
NRAS	Neuroblastoma RAS viral oncogene homolog
OS	overall survival
PD	progressive disease
PFS	progression-free survival
PR	partial response
R0 resection	resection margin (0) without cancer cells microscopically at the primary tumour site
RAS	Rat sarcoma proto-oncogene
RMS	remission-free survival
SD	stable disease
UICC	Union for International Cancer Control